Products

What will AGI do for Balsalazide disodium?

This classification denotes an anti-infective agent with the molecular formula C17H13N3O6.2NA.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1XL6BJI034. European Medicines Agency schedules balsalazide disodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB35314. The term balsalazide disodium is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule balsalazide disodium under HS 29270000. As of Q4 2014, BALSALAZIDE DISODIUM remains US FDA's Preferred Term for this commodity. Balsalazide disodium bears US NLM identifiers UMLS ID C0595398 and NCI Concept Code C47409. SMILES: C1CC(CCC1C(=O)NCCC(=O)[O-])/N=N/C2CCC(C(C2)C(=O)[O-])O.O.O.[NA+].[NA+].

How AGI delivers it

Four ways AGI delivers for Balsalazide disodium

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Balsalazide disodium, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Balsalazide disodium, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Balsalazide disodium connects

measured by

  • Assaymodel
  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Loss On Dryingmodel
  • Moisture Contentmodel
  • Puritymodel
  • Residual Solventmodel